When should ATTR-CM be suspected and how to diagnose it

Open Access

When should ATTR-CM be suspected and how to diagnose it

Session: The journey to improved outcomes in transthyretin amyloid cardiomyopathy (ATTR-CM)

Topic: Cardiac Amyloidosis

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES) Professor T. Damy (Creteil, FR) Professor N. Ajmone Marsan (Leiden, NL) Professor P. Elliott (London, GB)

About the speakers

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

81 presentations

22 followers

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

43 presentations

3 followers

Professor Nina Ajmone Marsan

Leiden University Medical Center, Leiden (Netherlands (The))

74 presentations

44 followers

Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

70 presentations

35 followers

3 more presentations in this session

Recognising the true impact of ATTR-CM on your patients

Speaker: Professor N. Ajmone Marsan (Leiden, NL) Professor T. Damy (Creteil, FR) Doctor P. Garcia-Pavia (Majadahonda, ES) Professor P. Elliott (London, GB)

Access

Slides

Managing ATTR-CM: from clinical trials to real-world experiences

Speaker: Professor P. Elliott (London, GB) Professor T. Damy (Creteil, FR) Professor N. Ajmone Marsan (Leiden, NL) Doctor P. Garcia-Pavia (Majadahonda, ES)

Access

Q&A

Access

Access the full session

The journey to improved outcomes in transthyretin amyloid cardiomyopathy (ATTR-CM)

Speakers: Doctor P. Garcia-Pavia, Professor T. Damy, Professor N. Ajmone Marsan, Professor P. Elliott, Professor N. Ajmone Marsan...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources